Table of Contents

2019-2024 Global Risedronate Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Risedronate Consumption 2014-2024
2.1.2 Risedronate Consumption CAGR by Region
2.2 Risedronate Segment by Type
2.2.1 5 mg Tablets
2.2.2 35 mg Tablets
2.2.3 75 mg Tablets
2.2.4 150 mg Tablets
2.3 Risedronate Consumption by Type
2.3.1 Global Risedronate Consumption Market Share by Type (2014-2019)
2.3.2 Global Risedronate Revenue and Market Share by Type (2014-2019)
2.3.3 Global Risedronate Sale Price by Type (2014-2019)
2.4 Risedronate Segment by Application
2.4.1 Postmenopausal Osteoporosis
2.4.2 Men with Osteoporosis
2.5 Risedronate Consumption by Application
2.5.1 Global Risedronate Consumption Market Share by Application (2014-2019)
2.5.2 Global Risedronate Value and Market Share by Application (2014-2019)
2.5.3 Global Risedronate Sale Price by Application (2014-2019)

3 Global Risedronate by Players
3.1 Global Risedronate Sales Market Share by Players
3.1.1 Global Risedronate Sales by Players (2017-2019)
3.1.2 Global Risedronate Sales Market Share by Players (2017-2019)
3.2 Global Risedronate Revenue Market Share by Players
3.2.1 Global Risedronate Revenue by Players (2017-2019)
3.2.2 Global Risedronate Revenue Market Share by Players (2017-2019)
3.3 Global Risedronate Sale Price by Players
3.4 Global Risedronate Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Risedronate Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Risedronate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Risedronate by Regions
4.1 Risedronate by Regions
4.1.1 Global Risedronate Consumption by Regions
4.1.2 Global Risedronate Value by Regions
4.2 Americas Risedronate Consumption Growth
4.3 APAC Risedronate Consumption Growth
4.4 Europe Risedronate Consumption Growth
4.5 Middle East & Africa Risedronate Consumption Growth

5 Americas
5.1 Americas Risedronate Consumption by Countries
5.1.1 Americas Risedronate Consumption by Countries (2014-2019)
5.1.2 Americas Risedronate Value by Countries (2014-2019)
5.2 Americas Risedronate Consumption by Type
5.3 Americas Risedronate Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Risedronate Consumption by Countries
6.1.1 APAC Risedronate Consumption by Countries (2014-2019)
6.1.2 APAC Risedronate Value by Countries (2014-2019)
6.2 APAC Risedronate Consumption by Type
6.3 APAC Risedronate Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Risedronate by Countries
7.1.1 Europe Risedronate Consumption by Countries (2014-2019)
7.1.2 Europe Risedronate Value by Countries (2014-2019)
7.2 Europe Risedronate Consumption by Type
7.3 Europe Risedronate Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Risedronate by Countries
8.1.1 Middle East & Africa Risedronate Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Risedronate Value by Countries (2014-2019)
8.2 Middle East & Africa Risedronate Consumption by Type
8.3 Middle East & Africa Risedronate Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Risedronate Distributors
10.3 Risedronate Customer

11 Global Risedronate Market Forecast
11.1 Global Risedronate Consumption Forecast (2019-2024)
11.2 Global Risedronate Forecast by Regions
11.2.1 Global Risedronate Forecast by Regions (2019-2024)
11.2.2 Global Risedronate Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Risedronate Forecast by Type
11.8 Global Risedronate Forecast by Application

12 Key Players Analysis
12.1 Merck
12.1.1 Company Details
12.1.2 Risedronate Product Offered
12.1.3 Merck Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Merck News
12.2 Amgen
12.2.1 Company Details
12.2.2 Risedronate Product Offered
12.2.3 Amgen Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Amgen News
12.3 Teva
12.3.1 Company Details
12.3.2 Risedronate Product Offered
12.3.3 Teva Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Teva News
12.4 Mylan
12.4.1 Company Details
12.4.2 Risedronate Product Offered
12.4.3 Mylan Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 Apotex
12.5.1 Company Details
12.5.2 Risedronate Product Offered
12.5.3 Apotex Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Apotex News
12.6 Sanofi
12.6.1 Company Details
12.6.2 Risedronate Product Offered
12.6.3 Sanofi Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Sanofi News
12.7 Abbott
12.7.1 Company Details
12.7.2 Risedronate Product Offered
12.7.3 Abbott Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Abbott News
12.8 Novartis
12.8.1 Company Details
12.8.2 Risedronate Product Offered
12.8.3 Novartis Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Novartis News
12.9 Tecoland
12.9.1 Company Details
12.9.2 Risedronate Product Offered
12.9.3 Tecoland Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Tecoland News
12.10 Taj Pharmaceuticals
12.10.1 Company Details
12.10.2 Risedronate Product Offered
12.10.3 Taj Pharmaceuticals Risedronate Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Taj Pharmaceuticals News

13 Research Findings and Conclusion